Eagle Pharmaceuticals
EGRX
#11107
Rank
S$4.19 M
Marketcap
S$0.32
Share price
0.00%
Change (1 day)
-89.54%
Change (1 year)

Market capitalization of Eagle Pharmaceuticals (EGRX)

Market cap: S$4.19 Million

As of September 2026 Eagle Pharmaceuticals has a market cap of S$4.19 Million. This makes Eagle Pharmaceuticals the world's 11107th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Eagle Pharmaceuticals from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026S$4.19 M-43.94%
2025S$7.48 M-22.72%
2024S$9.68 M-89.2%
2023S$89.7 M-82.41%
2022S$0.51 B-42.63%
2021S$0.88 B10.74%
2020S$0.80 B-27.29%
2019S$1.10 B44.16%
2018S$0.76 B-28.17%
2017S$1.06 B-40.01%
2016S$1.77 B-9.39%
2015S$1.96 B582.2%
2014S$0.28 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
S$828.64 B 19,742,033.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$341.92 B 8,146,180.63%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
S$1.325 T 31,579,652.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$271.22 B 6,461,736.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$163.22 B 3,888,610.81%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$130.54 B 3,110,001.88%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
S$59.61 B 1,420,276.18%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel